Members survey is now live!
We need you to help us help you. Given the realities of a COVID world we have prepared a survey that will enable us to respond to this changing environment. […]
We need you to help us help you. Given the realities of a COVID world we have prepared a survey that will enable us to respond to this changing environment. […]
Telehealth for delivery of haemophilia comprehensive care during the COVID‐19 pandemic O’Donovan, M, Buckley, C, Benson, J, et al. Telehealth for delivery of haemophilia comprehensive care during the COVID‐19 pandemic. Haemophilia. 2020; 00: 1– 7. https://doi.org/10.1111/hae.14156 The COVID‐19 pandemic […]
Event Registration / Inscription à l’événement This session is intended for Canadian patients and caregivers only. Learning Objectives: Overview of current treatment approaches for non-inhibitor hemophilia A patients in Canada […]
SWOR Family Community Day Hemophilia Ontario is hosting our first physical program of 2020 in the SWOR region! We are hosting an afternoon at Boler Mountain on October […]
Webinar presented by Kay Decker. A tool to help personalize your Prophylactic Therapy. Prophylactic replacement with factor concentrate is the optimal treatment for people with severe hemophilia to avoid or […]
Led by content leads, Alok Srivastava, MD, and Glenn Pierce, MD, PhD, WFH Vice-President, Medical, the 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management […]
The Women’s With Bleeding Disorders Web Series is Back! We are offering two more sessions with new topics and new speakers! August 8th 10am – 12pm – Women With Bleeding […]
Check out some of the links below: Complications from COVID-19 May Depend on von Willebrand Factor in the Blood by St. Petersburg State University https://medicalxpress.com/news/2020-07-complications-covid-von-willebrand-factor.html The World’s […]
On Thursday July 30 at 10:00am (EST), the World Federation of Hemophilia (WFH) will be hosting a 75-minute webinar for people with bleeding disorders to address concerns […]
A healthcare company is conducting market research with patients who are 18 years and older currently taking factor 8 replacement products. If you are interested, please contact the […]